1. Home
  2. VHC vs ATYR Comparison

VHC vs ATYR Comparison

Compare VHC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$16.55

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
ATYR
Founded
2005
2005
Country
United States
United States
Employees
N/A
58
Industry
Multi-Sector Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
73.7M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
VHC
ATYR
Price
$16.55
$0.84
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
21.6K
948.2K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
N/A
EPS
N/A
N/A
Revenue
$162,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
N/A
52 Week Low
$6.60
$0.64
52 Week High
$29.00
$7.29

Technical Indicators

Market Signals
Indicator
VHC
ATYR
Relative Strength Index (RSI) 50.33 50.60
Support Level $12.95 $0.68
Resistance Level $18.27 $0.86
Average True Range (ATR) 1.53 0.05
MACD 0.23 0.01
Stochastic Oscillator 44.67 70.88

Price Performance

Historical Comparison
VHC
ATYR

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: